Global Immune Checkpoint Inhibitors Market By Type (CTLA-4 inhibitor, PD-1 inhibitor, PD-L1 inhibitor) By Disease Indication (Lung Cancer, Bladder Cancer, Melanoma, Colorectal Cancer, Hodgkin lymphoma, Others) By End-User (Hospitals, Specialty Clinics, Academic & Research Institutions) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Aug 2024
- Report ID: 127673
- Number of Pages: 293
- Format:
-
-
-
- AstraZeneca Plc Company Profile
- F. Hoffmann-La Roche Ltd.
- Merck KGaA Company Profile
- Regeneron Pharmaceuticals, Inc.
- Bristol-Myers Squibb Company
- Innovent Biologics, Inc.
- BeiGene, Ltd.
- Shanghai Junshi Biosciences Co., Ltd.
- GlaxoSmithKline plc
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible